Hydrogel Medical Device Development: A Journey From Ideation To Market Release Under The Ai Startlight

Abstract

Hydrogel Medical Devices (HMDs) represent a cornerstone of biomedical innovation, yet their translation from concept to clinical practice is fraught with technical and regulatory challenges. This process is governed by the lifecycle-oriented framework of the European Medical Device Regulation (MDR), which imposes a considerable burden of evidence on manufacturers. Each stage of the development process involves a wide range of problems: The vast range of material options and properties during material design; the combinatorial complexity during formulation; the need for consistency and scalability during manufacturing; the ethical and translational limitations of preclinical testing; and the administrative burden of clinical evidence generation and post-market surveillance. This review examines each stage of this process under the MDR, their inherent challenges, and explores the potential for Artificial Intelligence (AI) to accelerate and de-risk this journey. Subsequently, the implications and added challenges from implementing AI methods are discussed, and key objectives to improve its implementation are defined. While AI offers powerful tools for the advancement of HMDs, ultimately, realizing the full potential of AI will depend on our commitment to review and improve the way we generate and share data, and to refine its surrounding infrastructure through collaboration between academia, industry and regulation entities.